Evaluate analgesic efficacy and safety of MoxDuo IR in patients with moderate to severe post-operative pain following total knee replacement surgery. [ + ]

Living Cell Technologies received 10 per cent of US startup, CytoSolv, in exchange for technology licence. [ + ]

Dynamin-1, plays a key role in the endocytosis at the synapse and the activity of neurotransmitters. Professor Phil Robinson is revealing the behaviour of this pivotal protein and its role in diseases like epilepsy. [ + ]

APVMA registers Erimophilone Oil as an active ingredient, end-user product could be available within two years. [ + ]

CSL, ResMed, Living Cell Technology, Mesoblast, Prima BioMed, Sirtex Medical, CathRx [ + ]

Researchers at the WEHI have identified a protein that could present an attractive drug target to prevent the parasite's spread through the blood. [ + ]

A collaborative venture between Sarah Russell at Peter Mac and microscopists at Swinbourne University of Technology is yielding insights into the behaviour of T cells. [ + ]

CathRX, Mesoblast, ChemGenex, Living Cell Technologies, QRxPharma, CSL, ResMed, Cochlear [ + ]

Australian and international researchers identify an enzyme that could prove an effective anti-malaria drug target. [ + ]

Lilly to use Starpharma's dendrimer drug delivery technology for human pharmaceuticals. [ + ]

Indium phosphide, di-tert-butyl peroxide and trixylyl phosphate have been looked at by the Committee for Risk Assessment (RAC) of ECHA (European Chemicals Agency in Helsinki).

Nine Australia Fellowships, worth $36 million in total, have been awarded by the NHMRC. [ + ]

UPDATED: Thermo Fisher Scientific goes direct with range of product lines. [ + ]

Collaboration between Patrys and CSL sends Patrys stocks soaring. [ + ]

Dr Owen Maroney claims we can remember in a reversed universe and it's all to do with the heat coming from your computer.